Literature DB >> 23935311

Stroboscopy for benign laryngeal pathology in evidence based health care.

A Printza1, S Triaridis, C Themelis, J Constantinidis.   

Abstract

BACKGROUND AND AIMS: Voice disorders are common. The aim of this study is to evaluate the diagnostic value of stroboscopy for voice disorders related with benign pathology and apply results in evidence based health care.
METHODS: Prospective study. Tertiary care hospital. Voice Clinic. One hundred and fifty consecutive patients with an initial diagnosis of benign laryngeal disease or dysphonia of no clarified cause (normal laryngoscopy) were examined stroboscopically and studied prospectively until a final diagnosis was reached. Sixty-six men, eighty women and four children met the selection criteria for the study and had adequate follow-up. The initial laryngoscopic diagnosis was compared to the stroboscopic diagnosis. The diagnostic value of stroboscopy was rated at a scale of 0 to 3. A score 3 describes the diagnostic value of stroboscopy in the cases where the stroboscopic examination resulted to a change of the therapeutic modality offered to the patient.
RESULTS: For one third of the study's population the diagnostic value of stroboscopy was very significant, since it established the laryngeal pathology responsible for the voice disorder (28.8%) and for a small number of patients it changed the choice of treatment (4.7%). For about one third of the cases (32.2%) stroboscopy offered additional information regarding the cause of dysphonia. The diagnostic value of stroboscopy correlated with the type of laryngeal pathology.
CONCLUSIONS: Patients expected to benefit from stroboscopic examination are patients with small lesions of the vocal fold edge, dysphonic patients with unremarkable indirect laryngoscopy, and professional voice users.

Entities:  

Keywords:  diagnosis; dysphonia; evidence based; health care; stroboscopy; voice disorders

Year:  2012        PMID: 23935311      PMCID: PMC3738606     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  22 in total

1.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS).

Authors:  P H Dejonckere; P Bradley; P Clemente; G Cornut; L Crevier-Buchman; G Friedrich; P Van De Heyning; M Remacle; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-02       Impact factor: 2.503

2.  Assessing laryngopharyngeal reflux symptoms with the Reflux Symptom Index: validation and prevalence in the Greek population.

Authors:  Athanasia Printza; Athanassios Kyrgidis; Eirini Oikonomidou; Stefanos Triaridis
Journal:  Otolaryngol Head Neck Surg       Date:  2011-10-10       Impact factor: 3.497

3.  Quality-of-life assessment in patients with unilateral vocal cord paralysis.

Authors:  B C Spector; J L Netterville; C Billante; J Clary; L Reinisch; T L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2001-09       Impact factor: 3.497

4.  Benign lesions of the vocal folds: histopathology and phonotrauma.

Authors:  F G Dikkers; P G Nikkels
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-09       Impact factor: 1.547

5.  Immunohistochemical characterization of benign laryngeal lesions.

Authors:  M S Courey; J A Shohet; M A Scott; R H Ossoff
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-07       Impact factor: 1.547

6.  Voice disorders in the general population: prevalence, risk factors, and occupational impact.

Authors:  Nelson Roy; Ray M Merrill; Steven D Gray; Elaine M Smith
Journal:  Laryngoscope       Date:  2005-11       Impact factor: 3.325

7.  Examiner bias: influence of patient history on perceptual ratings of videostroboscopy.

Authors:  N Teitler
Journal:  J Voice       Date:  1995-03       Impact factor: 2.009

8.  Diagnosis and treatment of persistent dysphonia after laryngeal surgery: a retrospective analysis of 62 patients.

Authors:  P Woo; J Casper; R Colton; D Brewer
Journal:  Laryngoscope       Date:  1994-09       Impact factor: 3.325

9.  Epidermoid cysts, sulci, and mucosal bridges of the true vocal cord: a report of 157 cases.

Authors:  M Bouchayer; G Cornut; E Witzig; R Loire; J B Roch; R W Bastian
Journal:  Laryngoscope       Date:  1985-09       Impact factor: 3.325

10.  Cross-cultural adaptation and validation of the voice handicap index into Greek.

Authors:  Meropi E Helidoni; Thomas Murry; Joanna Moschandreas; Christos Lionis; Athanasia Printza; George A Velegrakis
Journal:  J Voice       Date:  2008-08-26       Impact factor: 2.009

View more
  5 in total

1.  Evaluation of Various Laryngeal Pathologies: Videolaryngoscopy Versus Videolaryngostroboscopy.

Authors:  Maitri Rahul Kaushik; Amit Sharad Kole; Nishit Gupta; Sarika Dhoot; Arun Dehadaray
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-04-06

2.  Change in diagnosis and treatment following specialty voice evaluation: A national database analysis.

Authors:  Seth M Cohen; Jaewhan Kim; Nelson Roy; Amber Wilk; Steven Thomas; Mark Courey
Journal:  Laryngoscope       Date:  2015-02-13       Impact factor: 3.325

3.  Efficacy of Videostroboscopy and High-Speed Videoendoscopy to Obtain Functional Outcomes From Perioperative Ratings in Patients With Vocal Fold Mass Lesions.

Authors:  Maria E Powell; Dimitar D Deliyski; Steven M Zeitels; James A Burns; Robert E Hillman; Terri Treman Gerlach; Daryush D Mehta
Journal:  J Voice       Date:  2019-04-17       Impact factor: 2.009

4.  Frequency and factors associated with use of videolaryngostroboscopy in voice disorder assessment.

Authors:  Seth M Cohen; Steven Thomas; Nelson Roy; Jaewhan Kim; Mark Courey
Journal:  Laryngoscope       Date:  2014-05-07       Impact factor: 3.325

5.  Evaluation of clinical value of videokymography for diagnosis and treatment of voice disorders.

Authors:  Ketaki Vasant Phadke; Jitka Vydrová; Romana Domagalská; Jan G Švec
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-08-30       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.